BENZODIAZEPINE RECEPTOR QUANTIFICATION IN-VIVO IN HUMANS USING [C-11] FLUMAZENIL AND PET - APPLICATION OF THE STEADY-STATE PRINCIPLE

被引:173
|
作者
LASSEN, NA
BARTENSTEIN, PA
LAMMERTSMA, AA
PREVETT, MC
TURTON, DR
LUTHRA, SK
OSMAN, S
BLOOMFIELD, PM
JONES, T
PATSALOS, PN
OCONNELL, MT
DUNCAN, JS
ANDERSEN, JV
机构
[1] NOVO NORDISK AS, DEPT DRUG METAB, DIV CNS, MALOV, DENMARK
[2] HAMMERSMITH HOSP, MRC, CYCLOTRON UNIT, LONDON W12 0HS, ENGLAND
[3] NATL HOSP, DEPT CLIN NEUROL, LONDON WC1N 3BG, ENGLAND
来源
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 1995年 / 15卷 / 01期
关键词
BENZODIAZEPINE RECEPTORS (IN VIVO; FLUMAZENIL; POSITRON EMISSION TOMOGRAPHY; RO; 15-1788;
D O I
10.1038/jcbfm.1995.17
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Carbon-11-labeled flumazenil combined with positron emission tomography (PET) was used to measure the concentration (B-max) of the benzodiazepine (Bz) receptor in the brain and its equilibrium dissociation constant (K-D) for flumazenil in five normal subjects. The steady-state approach was used injecting the tracer as a bolus of high specific activity. In each subject two studies were carried out. The first study was performed at essentially zero receptor occupancy, the tracer alone study. The second study was performed at a steady-state receptor occupancy of about 50%, achieved by a prolonged constant infusion of nonlabeled (''cold'') flumazenil starting 2 h before the bolus tracer injection and continuing until the end of the scanning period. In this second study the free concentration of unmetabolized flumazenil in plasma water was measured in multiple blood samples. The observed tissue and plasma tracer curves, calibrated in the same units of radioactivity per millimeter, were analyzed in two ways: (a) by the noncompartmental (stochastic) approach making no assumptions regarding number of compartments in the tissue, and (b) by the single-compartment approach assuming rapid exchange (mixing) of tracer between all tissue compartments. The noncompartmental and the compartmental analyses gave essentially the same values for the distribution volume of the tracer, the parameter used for quantitation of the Bz receptor. As the compartmental approach could be applied to a shorter observation period (60 min instead of 120 min) it was preferred. The five subjects had a mean K-D value of 12 nM/L of water and B-max values of the grey matter ranging from 39 +/- 11 in thalamus to 120 +/- 14 nM/L of brain in occipital cortex. Most previous studies have been based on the pseudoequilibrium approach using the brain stem as a receptor-free reference region. This yields practically the same K-D but lower B-max values than the steady-state approach presented here.
引用
收藏
页码:152 / 165
页数:14
相关论文
共 50 条
  • [31] Simultaneous in vivo measurements of receptor density and affinity using [11C] flumazenil and positron emission tomography: Comparison of full saturation and steady state methods
    Syvanen, Stina
    de Lange, Elizabeth C.
    Tagawa, Yoshihiko
    Schenke, Maarten
    Molthoff, Carla F. M.
    Windhorst, Albert D.
    Lammertsma, Adriaan A.
    Voskuyl, Rob A.
    NEUROIMAGE, 2011, 57 (03) : 928 - 937
  • [32] LABELLING AND IN-VIVO EVALUATION IN BABOONS OF A NOVEL [11C]-CARBON LABELLED IMIDAZOPYRIDINE, FOR THE STUDY OF THE PERIPHERAL BENZODIAZEPINE RECEPTORS USING PET
    Bourdier, T.
    Henderson, D.
    Lam, P.
    Fookes, C.
    Mattner, F.
    Greguric, I.
    Pham, T.
    Eberl, S.
    Wen, L.
    Katsifis, A.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S347 - S347
  • [33] Effect of age, gender and BMI on in-vivo CB1 receptor availability in humans measured with [11C]OMAR PET
    Radhakrishnan, R.
    Worhunsky, P.
    Gallezot, J. D.
    Nabulsi, N.
    Skosnik, P. D.
    D'Souza, D. C.
    Potenza, M. N.
    Carson, R. E.
    Huang, Y.
    Matuskey, D.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 : 563 - 563
  • [34] Impaired benzodiazepine receptor binding in peri-lesional cortex of patients with symptomatic epilepsies studied by [11C]-flumazenil PET
    Szelies, B
    Sobesky, J
    Pawlik, G
    Mielke, R
    Bauer, B
    Herholz, K
    Heiss, WD
    EUROPEAN JOURNAL OF NEUROLOGY, 2002, 9 (02) : 137 - 142
  • [35] Initial kinetic analyses of the in vivo binding of the putative NMDA receptor ligand [C-11]CNS 5161 in humans
    Asselin, MC
    Hammers, A
    Turton, D
    Osman, S
    Koepp, M
    Brooks, D
    NEUROIMAGE, 2004, 22 : T137 - T138
  • [36] IN-VIVO MEASUREMENT OF ANP OVERALL TURNOVER AND IDENTIFICATION OF ITS MAIN METABOLIC PATHWAYS UNDER STEADY-STATE CONDITIONS IN HUMANS
    CLERICO, A
    IERVASI, G
    BERTI, S
    PILO, A
    VITEK, F
    SALVADORI, S
    MARASTONI, M
    MANFREDI, C
    DELCHICCA, MG
    IASCONE, MR
    BIAGINI, A
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1995, 18 (03) : 194 - 204
  • [37] RESULTS - STEADY-STATE AND PULSED (CO2)-C-11 ANALYSIS OF PHOTOSYNTHESIS AND ALLOCATION IN LIVE, INTACT PLANTS
    GOESCHL, JD
    SHARPE, PJH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1979, (SEP): : 82 - 82
  • [38] SYNTHESIS OF 2'-FLUORO-5-[C-11]-METHYL-1-BETA-D-ARABINOFURANOSYLURACIL ([C-11]-FMAU) - A POTENTIAL NUCLEOSIDE ANALOG FOR IN-VIVO STUDY OF CELLULAR PROLIFERATION WITH PET
    CONTI, PS
    ALAUDDIN, MM
    FISSEKIS, JR
    SCHMALL, B
    WATANABE, KA
    NUCLEAR MEDICINE AND BIOLOGY, 1995, 22 (06) : 783 - 789
  • [39] 11C-DPA-713:: A novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation
    Boutin, Herve
    Chauveau, Fabien
    Thominiaux, Cyrille
    Gregoire, Marie-Claude
    James, Michelle L.
    Trebossen, Regine
    Hantraye, Philippe
    Dolle, Frederic
    Tavitian, Bertrand
    Kassiou, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (04) : 573 - 581
  • [40] COMPARTMENTAL ANALYSIS OF [C-11] FLUMAZENIL KINETICS FOR THE ESTIMATION OF LIGAND TRANSPORT RATE AND RECEPTOR DISTRIBUTION USING POSITRON EMISSION TOMOGRAPHY
    KOEPPE, RA
    HOLTHOFF, VA
    FREY, KA
    KILBOURN, MR
    KUHL, DE
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1991, 11 (05): : 735 - 744